Clinical Development
Focused on patients, committed to success
Transforming biologically active compounds and new chemical entities into effective medicines of the highest quality to safeguard patients’ health is the mission of Merck Serono’s Clinical Development organisation.
We are committed to the development of innovative and efficacious therapies for patients with significant unmet medical needs. Our R&D pipeline currently includes approximately 30 projects in clinical development.
The global development structure within Merck Serono is ensured by some 800 medical directors, scientists and administrative personnel located at three main sites in Boston, Darmstadt and Geneva.
Development works hand-in-hand with Research to ensure the safe transition from pre-clinical testing to man of our innovative compounds as they enter the development pipeline. We also support the successful commercialisation of our drug products by providing medical expertise at all levels of the Merck Serono organisation. We further support our Portfolio Management and Business Development team with strategic alliances and co-development projects with other pharmaceutical and biotechnology partners.
